Entering text into the input field will update the search result below

Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 41st Annual Global Healthcare Conference (Transcript)

Jun. 12, 2020 11:05 PM ETBristol-Myers Squibb Company (BMY), BMYMP2 Comments
SA Transcripts profile picture
SA Transcripts

Bristol-Myers Squibb Company (NYSE:BMY) Goldman Sachs 41st Annual Global Healthcare Conference June 11, 2020 3:00 PM ET

Company Participants

Nadim Ahmed - EVP and President Hematology

Chris Boerner - EVP, Chief Commercialization Officer

Conference Call Participants

Terence Flynn - Goldman Sachs

Terence Flynn

Great. Good afternoon everybody. I'm Terence Flynn, the Biopharma Analyst at Goldman Sachs, and we're very pleased to welcome Bristol-Myers Squibb today to our virtual conference. Joining us from the Company is Nadim Ahmed, who is Executive Vice President and President of Hematology; Chris Boerner, who is Executive Vice President and Head Commercial -- Chief Commercial Officer. I am looking forward to hosting you both today. Thank you for taking time out of your day to join us.

Question-and-Answer Session

Q - Terence Flynn

Maybe just to get started, and again, maybe Chris, this one would be for you and then Nadim, you could add on anything here. We're obviously into June and some states are starting to reopen now and just wanted to check in on the operating environment and how that's tracking relative to the expectations that you outlined on your first quarter call, where you said, you saw more of a return to a more stable environment in the third quarter? And then maybe any commentary across the key-end markets that you guys operate in?

Chris Boerner

Sure, maybe I'll start and Nadim can chime in as well. So what I would say at a high level is the teams are managing through COVID quite well. The fundamentals of our business remained very strong, and importantly, we're in the process of building what we think is going to be the leading biopharmaceutical company post the acquisition of Celgene, and that importantly remains on track.

From a business standpoint, what we said in the first quarter

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.